CompletedPhase 2NCT01824693
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia
Studying Juvenile myelomonocytic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Christopher Dvorak, PTAChildren's Oncology Group
- Intervention
- Allogeneic Hematopoietic Stem Cell Transplantation(procedure)
- Enrollment
- 30 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2017
Study locations (30)
- Children's Hospital of Alabama, Birmingham, Alabama, United States
- Phoenix Childrens Hospital, Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- Mattel Children's Hospital UCLA, Los Angeles, California, United States
- Children's Hospital of Orange County, Orange, California, United States
- Rady Children's Hospital - San Diego, San Diego, California, United States
- UCSF Medical Center-Parnassus, San Francisco, California, United States
- UCSF Medical Center-Mission Bay, San Francisco, California, United States
- Alfred I duPont Hospital for Children, Wilmington, Delaware, United States
- Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, United States
- Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
- Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States
- Lurie Children's Hospital-Chicago, Chicago, Illinois, United States
- Riley Hospital for Children, Indianapolis, Indiana, United States
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01824693 on ClinicalTrials.govOther trials for Juvenile myelomonocytic leukemia
Additional recruiting or active studies for the same condition.